A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)

PHASE3RecruitingINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

November 28, 2024

Primary Completion Date

April 12, 2027

Study Completion Date

July 5, 2027

Conditions
Lichen Simplex Chronicus
Interventions
DRUG

Dupilumab

Pharmaceutical form: Solution for injection Route of administration: subcutaneous injection

DRUG

Placebo

Pharmaceutical form: Solution for injection Route of administration: subcutaneous injection

Trial Locations (63)

833

RECRUITING

Investigational Site Number : 1580002, Kaohsiung City

1015

RECRUITING

Investigational Site Number : 0320001, CABA

4032

RECRUITING

Investigational Site Number : 3480001, Debrecen

5500

RECRUITING

Investigational Site Number : 0320002, Mendoza

7400

RECRUITING

Investigational Site Number : 3480002, Kaposvár

10002

RECRUITING

Investigational Site Number : 1580001, Taipei

10023

RECRUITING

Equity Medical- Site Number : 8400017, New York

12462

RECRUITING

Investigational Site Number : 3000001, Athens

20127

RECRUITING

Investigational Site Number : 4840003, Aguascalientes

22206

RECRUITING

Care Access - Arlington- Site Number : 8400022, Arlington

23538

RECRUITING

Investigational Site Number : 2760002, Lübeck

23561

NOT_YET_RECRUITING

Investigational Site Number : 1580003, New Taipei City

31000

RECRUITING

Investigational Site Number : 4840001, Chihuahua City

33142

RECRUITING

Quality Care Clinical Research- Site Number : 8400034, Miami

34662

RECRUITING

Investigational Site Number : 7920002, Istanbul

39104

RECRUITING

Investigational Site Number : 2760001, Magdeburg

40138

RECRUITING

Investigational Site Number : 3800002, Bologna

46015

RECRUITING

Investigational Site Number : 7240004, Valencia

48346

RECRUITING

Michigan Center for Research Company- Site Number : 8400013, Clarkston

48455

RECRUITING

Investigational Site Number : 2760003, Bad Bentheim

54290

RECRUITING

Investigational Site Number : 7920003, Sakarya

54642

RECRUITING

Investigational Site Number : 3000002, Thessaloniki

55200

RECRUITING

Investigational Site Number : 7920001, Samsun

56403

RECRUITING

Investigational Site Number : 3000003, Thessaloniki

58103

RECRUITING

Red River Research Partners - Fargo- Site Number : 8400007, Fargo

77004

RECRUITING

Center for Clinical Studies - Houston - Binz Street- Site Number : 8400011, Houston

77090

RECRUITING

MedCare Pharma - Houston - Cypress Creek Parkway- Site Number : 8400014, Houston

89148

RECRUITING

JDR Dermatology Research- Site Number : 8400023, Las Vegas

90045

RECRUITING

Dermatology Research Associates - Los Angeles- Site Number : 8400004, Los Angeles

100191

RECRUITING

Investigational Site Number : 1560002, Beijing

200443

RECRUITING

Investigational Site Number : 1560001, Shanghai

215006

RECRUITING

Investigational Site Number : 1560005, Suzhou

310014

RECRUITING

Investigational Site Number : 1560004, Hangzhou

7580206

RECRUITING

Investigational Site Number : 1520002, Santiago

7630000

RECRUITING

Investigational Site Number : 1520001, Vitacura

8420383

RECRUITING

Investigational Site Number : 1520003, Santiago

28078-7961

RECRUITING

Onsite Clinical Solutions - Huntersville- Site Number : 8400033, Huntersville

C1061AAS

RECRUITING

Investigational Site Number : 0320004, Capital Federal

S2000DBS

RECRUITING

Investigational Site Number : 0320003, Rosario

T5K 1X3

RECRUITING

Investigational Site Number : 1240005, Edmonton

N6H 5L5

RECRUITING

Investigational Site Number : 1240001, London

L4Y 4C5

RECRUITING

Investigational Site Number : 1240007, Mississauga

H1Y 3L1

RECRUITING

Investigational Site Number : 1240009, Montreal

S4V 1R9

RECRUITING

Investigational Site Number : 1240010, Regina

S7K 2C1

RECRUITING

Investigational Site Number : 1240002, Saskatoon

G1W 4R4

RECRUITING

Investigational Site Number : 1240008, Québec

050031

RECRUITING

Investigational Site Number : 1560003, Shijiazhuang

702 00

RECRUITING

Investigational Site Number : 2030001, Ostrava

00133

RECRUITING

Investigational Site Number : 3800001, Roma

819-0167

RECRUITING

Investigational Site Number : 3920009, Nishiku

890-0063

RECRUITING

Investigational Site Number : 3920005, Kagoshima

243-0432

RECRUITING

Investigational Site Number : 3920002, Ebina-shi

861-3106

RECRUITING

Investigational Site Number : 3920001, Kamimashiki-gun

593-8324

RECRUITING

Investigational Site Number : 3920007, Sakai-shi

190-0023

RECRUITING

Investigational Site Number : 3920003, Tachikawa-shi

3004-561

RECRUITING

Investigational Site Number : 6200002, Coimbra

1998-018

RECRUITING

Investigational Site Number : 6200003, Lisbon

4099-001

RECRUITING

Investigational Site Number : 6200001, Porto

08035

RECRUITING

Investigational Site Number : 7240003, Barcelona

08036

RECRUITING

Investigational Site Number : 7240005, Barcelona

08041

RECRUITING

Investigational Site Number : 7240002, Barcelona

MK19 6FG

RECRUITING

Investigational Site Number : 8260002, Milton Keynes

E1 1BB

RECRUITING

Investigational Site Number : 8260001, London

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY

NCT06687967 - A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1) | Biotech Hunter | Biotech Hunter